School of Medicine


Showing 1-20 of 123 Results

  • Karim Sallam, MD

    Karim Sallam, MD

    Assistant Professor of Medicine (Cardiovascular Medicine)

    BioKarim Sallam, MD, is trained in Cardiovascular Medicine and Advanced Heart Failure.

  • Arghavan Salles

    Arghavan Salles

    Clinical Associate Professor, Medicine - Gastroenterology & Hepatology

    BioDr. Salles is a minimally invasive and bariatric surgeon. She completed medical school and residency in general surgery at Stanford prior to completing her fellowship in minimally invasive surgery at Washington University in St. Louis. She stayed on faculty at Washington University for three years prior to moving back to Stanford in 2019.During the pandemic, Dr. Salles has served as a disaster relief physician, caring for patients with COVID in the ICU. Dr. Salles obtained a PhD in education from Stanford University during her residency training, and her research focuses on gender equity, implicit bias, diversity, inclusion, and physician well-being. Her R01 grant from the NIH focuses on sexual harassment. She is a sought-after speaker and has given over 100 national and international invited talks related to gender equity, physician well-being, and weight bias. She currently serves as the Special Advisor for DEI Programs at the Stanford University Department of Medicine where she is a Clinical Associate Professor.

  • Giselle (Ghazal) Salmasi, MD

    Giselle (Ghazal) Salmasi, MD

    Clinical Associate Professor, Medicine - Hematology

    BioDr. Salmasi is a board-certified, fellowship-trained hematologist. She treats patients in the Hematology Program and the Hematologic Cancer Program at Stanford Health Care. Dr. Salmasi is the associate clinical chief for classical hematology. She is also a clinical associate professor in the Division of Hematology, Department of Medicine at Stanford University School of Medicine.

    She treats a wide range of blood disorders and blood cancers. Her clinical/research interests include immune thrombocytopenia (ITP) and warm autoimmune hemolytic anemia (wAIHA). Dr. Salmasi understands that patients need social and emotional support along with medical care. She founded the earliest adolescent and young adult survivorship support groups in Santa Cruz, California, and Toronto, Canada. Dr. Salmasi is also dedicated to training future doctors in providing excellent hematologic care.

    Dr. Salmasi was the medical co-investigator for a national phase 3 clinical trial of endovascular therapy for treating chronic venous thrombosis.

    Her research has appeared in the New England Journal of Medicine, Leukemia & Lymphoma journal and the Transfusion and Apheresis Science journal. Dr. Salmasi’s publications include articles and a chapter about lymphoma. She has also reviewed articles for the Biology of Blood and Marrow Transplantation journal and the Journal of Clinical Oncology.

    Dr. Salmasi is a member of the American Society of Hematology.

  • Alexander Tarlochan Singh Sandhu

    Alexander Tarlochan Singh Sandhu

    Assistant Professor of Medicine (Stanford Prevention Research Center)

    BioAlex Sandhu, MD, MS is a cardiologist with a special interest in the care of patients with advanced heart failure. He graduated from the seven-year combined BA-MD program at Northwestern with a focus on economics and mathematics. He completed an internal medicine residency at Stanford University, spending 16 weeks at Makerere Hospital in Uganda as part of the Global Health track. He subsequently earned a Masters in Health Services Research at Stanford while acting as a fellow in health services research at the Palo Alto VA and Stanford's Center for Health Policy/Primary Care and Outcomes Research. Next, he completed fellowships in cardiology and advanced heart failure and transplant at Stanford before joining the faculty as an Assistant Professor in Stanford Cardiology and the Stanford Prevention Research Center.

    Alex is now an active clinician and clinical researcher who focuses on the implementation of high-value preventive strategies, comparative effectiveness, innovative clinical trial design, and health economics. He is passionate about testing patient-centered implementation strategies to bring meaningful improvements to patients’ lives and prevent disease morbidity. He is involved in several clinical trials including the K-23 funded PRO-HF (patient-centered quality of life assessments), DOT-HF (digital health study for HF patient activation), a CAC notification pilot trial (patient-centered coronary artery calcification notification), and PHARM-HF (testing strategies to improve HF management by pharmacists).

    In his free time, he enjoys playing soccer as well as entertaining and being entertained by his joyful kids, Kyle, Tyler, and Kira.

  • Ryan Sandoval, M.D.

    Ryan Sandoval, M.D.

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine

    BioDr. Sandoval is a board-certified cardiologist and a clinical assistant professor in the Division of Cardiovascular Medicine at Stanford University School of Medicine. He completed his residency at the University of Texas at Austin, where he continued on as chief resident before going on to complete his fellowship in cardiovascular disease at the Medical University of South Carolina. Prior to his residency, he completed a research fellowship at Massachusetts General Hospital (MGH).

    His clinical interests include preventive cardiology and management of heart failure. He is particularly focused on treating patients with the complex clinical syndrome of heart failure with preserved ejection fraction (HFpEF).

    His interest in preventive cardiology grew through his participation in clinics for the uninsured and underinsured during his training. These experiences fostered his passion for understanding and addressing health care disparities. He is deeply committed to providing exceptional patient care with a personalized approach to treatment and improving the lives of his patients.

    He is a member of the American College of Cardiology.

  • Rebecca Sands

    Rebecca Sands

    Clinical Associate Professor, Medicine - Primary Care and Population Health

    BioDr. Sands currently serves as the Clinical Section Chief of Palliative Care at Stanford University, where she directly supervises 13 physicians and oversees the inpatient and outpatient clinical programs at Stanford Health Care. She graduated from Franklin & Marshall College in 2001 with a BA in Chemistry. She then attended Midwestern University, Chicago College of Osteopathic Medicine from 2002-2006. She completed a residency and chief residency in Internal Medicine at Cambridge Health Alliance, a public teaching hospital of Harvard Medical School. She went on to complete her Hospice and Palliative Medicine (HPM) fellowship at the Harvard combined program at Massachusetts General Hospital/Dana Farber Cancer Institute in 2011. She spent 8 years at the University of Pittsburgh where she served as core teaching faculty and the HPM Fellowship Program Director. Since her recruitment to Stanford, her focus has been on programmatic expansion of clinical Palliative Care services across healthcare settings and throughout the trajectory of the serious illness experience. This has included recruitment of dually boarded faculty, development of an Emergency Palliative Care program, and many other new and innovative initiatives.

  • Christine Santiago

    Christine Santiago

    Clinical Assistant Professor, Medicine

    BioDr. Christine Santiago, M.D., M.P.H. is a Clinical Assistant Professor in the Stanford Division of Hospital Medicine, dedicated to improving healthcare access and equity. Dr. Santiago graduated cum laude with an M.D. from Harvard Medical School and completed an M.P.H. in Health Policy and Management at the University of California, Berkeley. She then completed her Internal Medicine Residency at Stanford University, where she also served as Chief Resident.

    Dr. Santiago has been a driving force behind several innovative curricular developments and community partnership initiatives. She co-founded and serves as the faculty director of the Stanford Health Equity, Advocacy, and Research Program. This program's mission is to train resident physicians to become leaders in health equity, equipped to serve their local communities effectively. She also co-founded the Hospital Medicine Health Equity Committee within Stanford's Division of Hospital Medicine, creating a structured platform for collaboration, idea sharing, and integration of health equity principles into various quality, research, and administrative initiatives. Furthermore, she has pioneered educational programs such as the Street Medicine Rotation, LGBTQ+ Clinical Rotation, and the Re-entry Medicine Rotation, creating significant opportunities for residents to gain invaluable experience in diverse healthcare settings.

    With a strong focus on health equity and healthcare access, Dr. Santiago has been actively involved in mentoring programs and has received numerous accolades, including the SHC Medical Staff Award for Diversity, Equity, and Inclusion and the Inspiring Early Academic Career Award. Her research and quality improvement initiatives, particularly in the realms of health equity and patient care optimization, highlight her unwavering commitment to creating a more inclusive and effective healthcare system.

  • Anuja Anand Sathe

    Anuja Anand Sathe

    Instructor, Medicine - Oncology

    Current Research and Scholarly InterestsI am interested in understanding the determinants of therapeutic resistance in cancer. I investigate the composition of the tumor microenvironment and adaptive responses to therapy using single-cell and spatial approaches.

  • Neda Sattarnezhad Oskouei, MD, MS

    Neda Sattarnezhad Oskouei, MD, MS

    Instructor, Medicine - Immunology & Rheumatology

    BioDr. Neda Sattarnezhad Oskouei is a board-certified neurologist and neuroimmunologist specializing in Multiple Sclerosis (MS) and neuroimmunological disorders, including Neuromyelitis Optica (NMO), MOG Antibody Disease (MOGAD), optic neuritis, transverse myelitis, autoimmune encephalitis, neuro-rheumatological conditions, and neuroinfectious diseases. Her research focuses on understanding the role of pathogens in triggering autoimmunity, with a particular emphasis on the role of Epstein-Barr Virus (EBV) in the development of MS.

    Dr. Sattarnezhad earned her MD degree with honors from Tabriz University of Medical Sciences. She completed a research fellowship in Multiple Sclerosis at the Brigham MS Center, Harvard Medical School, before pursuing her residency in adult neurology at the University of Illinois at Chicago. She further specialized by completing a clinical fellowship in Multiple Sclerosis and Neuroimmunology at Stanford University as a Sylvia Lawry Fellow of the National MS Society, during which she also earned a master’s degree in Epidemiology and Clinical Research. She subsequently completed a fellowship in immunology and rheumatology at Stanford.

    Her research and training have been supported by the National MS Society (NMSS), National Institutes of Health (NIH), and National Institute of Allergy and Infectious Diseases (NIAID). Dr. Sattarnezhad is a member of the American Academy of Neurology (AAN) and the Consortium of Multiple Sclerosis Centers (CMSC).

  • Amelia Sattler, MD

    Amelia Sattler, MD

    Clinical Associate Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly InterestsCurrently working on projects identifying effective use of actual patient encounters in undergraduate medical education. Specifically interested in the role of actual patient encounters in the training of shared decision making. Also interested in medical student empathy and physician wellness.

    Also working on many different projects in the realm of quality improvement and population health in the Division of Primary Care and Population Health.

  • John Scandling

    John Scandling

    Professor of Medicine (Nephrology) at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly InterestsTolerance induction in clinical kidney transplantation

  • Lidia Schapira

    Lidia Schapira

    Professor of Medicine (Oncology)

    BioDr. Schapira is a medical oncologist with clinical expertise in the treatment of breast cancer. As the inaugural Director of Stanford's Cancer Survivorship Program, she has developed a thriving research and clinical program focused on optimizing health outcomes for people living with and beyond cancer. Dr. Schapira is interested in training future generations of physician-scientists as well as the broader community of practicing physicians through the design of innovative educational programs. Dr. Schapira's advocacy for people with cancer led to her appointment as Editor-in-Chief of the American Society of Clinical Oncology's website for the public,Cancer.Net, a position she held from 2015 until-2021. She served on the Board of Directors of the American Psychosocial Oncology Society and as Chair of the Psychosocial Interest Group of the Multinational Society for Supportive Care in Cancer. Dr. Schapira is particularily committed to reducing inequities in cancer outcomes and improve access to cancer care and cancer clinical trials. Dr. Schapira has published numerous manuscripts, lectures both nationally and internationally on issues of cancer survivorship and served as Associate Editor of the narrative section, Art of Oncology, for the Journal of Clinical Oncology from 2013 until 2023.